SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Jun-22 4:10 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Jun-22 | Payment of Exercise | 10,920 | $2.86 | $31,231.20 | (7%) 159.0K to 148.08K | |
04-Mar-22 5:48 PM View: | Quince Therapeutics, Inc. (QNCX) | 03-Mar-22 | Grant | 155,500 | -- | -- | 4443% 3.5K to 159.0K | |
15-Dec-20 7:17 PM View: | Quince Therapeutics, Inc. (QNCX) | 14-Dec-20 | Option Exercise | 40,000 | $0.27 | $10,800.00 | 1143% 3.5K to 43.5K | |
15-Dec-20 7:17 PM View: | Quince Therapeutics, Inc. (QNCX) | 14-Dec-20 | Market Option Sale (Planned) | 40,000 | $30.81 | $1,232,530.00 | (92%) 43.5K to 3.5K | 4% |
14-Dec-20 5:16 PM View: | Quince Therapeutics, Inc. (QNCX) | 10-Dec-20 | Option Exercise | 3,500 | $0.27 | $945.00 | 100% 0 to 3.5K |